Search - tctmd.com

Displaying 101 - 120 of 392

Sort: Relevancy | Date

News Conference News SCAI 2022

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

L.A. McKeown

May 22, 2022

Presentation Fellows 2022

Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know

Presenter: Sahil Parikh

May 07, 2022

News Daily News

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

L.A. McKeown

April 27, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Daily News

Statins Underprescribed in PAD Before and After Interventions

L.A. McKeown

December 03, 2021

Presentation TCT 2021

Drug Elution Challenges and Opportunities

Presenter: Wojtek Wojakowski

November 06, 2021

Presentation TCT 2021

New Tech for CLI: Distal Access

Presenter: Arthur Lee

November 06, 2021

Presentation TCT 2021

New Tech for CLI: Atherectomy

Presenter: Peter Monteleone

November 06, 2021

Presentation TCT 2021

New Data on Racial Disparities

Presenter: Foluso Fakorede

November 06, 2021

Presentation TCT 2021

Opportunities to Improve Outcomes: IVUS

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

Atherectomy as an Adjunct to Long-term Patency

Presenter: Ravish Sachar

November 06, 2021

Presentation TCT 2021

Role of Drug Eluting Technologies as Definitive Therapy

Presenter: Thomas Zeller

November 06, 2021

Presentation TCT 2021

Case Presentation: Long Segment SFA Occlusion

Presenter: Mohammad Ansari

November 06, 2021

Presentation TCT 2021

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2021

Have We Gotten to the Final Word on Paclitaxel Safety?

Presenter: Eric Secemsky

November 06, 2021

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Connie Hess

November 06, 2021

Presentation TCT 2021

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

Presenter: Jacqueline Saw

November 06, 2021

Advertisement

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

PAD Significantly Ups Morbidity and Mortality in AMICS

TCTMD’s Top 10 Most Popular Stories for December 2021

Statins Underprescribed in PAD Before and After Interventions

Drug Elution Challenges and Opportunities

New Tech for CLI: Distal Access

New Tech for CLI: Atherectomy

New Data on Racial Disparities

Opportunities to Improve Outcomes: IVUS

Atherectomy as an Adjunct to Long-term Patency

Role of Drug Eluting Technologies as Definitive Therapy

Case Presentation: Long Segment SFA Occlusion

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Have We Gotten to the Final Word on Paclitaxel Safety?

Oral Anticoagulation Should Be the Default Strategy After LAAC

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content